NATH BIO-GENES (I) LTD vs NESTLE INDIA LIMITED
A side-by-side comparison of NATH BIO-GENES (I) LTD (NATHBIOGEN) and NESTLE INDIA LIMITED (NESTLEIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, NESTLE INDIA LIMITED leads NATHBIOGEN vs NESTLEIND on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation40
- Profitability04
- Growth20
- Size & financial health04
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
NATHBIOGEN takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
NESTLEIND takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
NATHBIOGEN takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
NESTLEIND takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Stock is trading at 0.44 times its book value", "Debtor days have improved from 110 to 70.0 days."]
- − ["Tax rate seems low", "Company has a low return on equity of 5.93% over last 3 years.", "Earnings include an other income of Rs.15.2 Cr.", "Dividend payout has been low at 9.52% of profits over last 3 years"]
- + ["Company has reduced debt.", "Company is almost debt free.", "Company has a good return on equity (ROE) track record: 3 Years ROE 92.3%", "Company has been maintaining a healthy dividend payout of 74.3%"]
- − ["Stock is trading at 52.8 times its book value", "The company has delivered a poor sales growth of 11.6% over past five years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.